TITLE:
Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion

CONDITION:
Arterial Occlusive Diseases

INTERVENTION:
Alfimeprase

SUMMARY:

      This trial is for patients with acute occlusion of one of the arteries supplying blood to
      the leg. The trial is designed to determine the safety and activity of a novel clot
      dissolving (thrombolytic) drug (alfimeprase).
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        -  Patients with acute peripheral arterial occlusion of the lower limb (onset of
             symptoms within 14 days)

          -  Rutherford Class I or IIa (minimal sensory loss, no muscle weakness, audible venous
             flow)

          -  Age 18 or above

          -  Able to consent

          -  Able to follow up
      
